The Latest in Follicular Lymphoma

DLBCL survival improved with novel antibody-drug conjugate

June 17, 2018

Follicular Lymphoma

‘Excellent’ survival with HCT despite early treatment failure in FL

June 16, 2018

Follicular Lymphoma

Chemo-free combo provides potential first-line option for FL

June 12, 2018

Follicular Lymphoma

Polatuzumab plus BR improves efficacy in DLBCL

June 8, 2018

Follicular Lymphoma

Chemo-free regimen appears viable in previously untreated FL

June 7, 2018

Follicular Lymphoma

Novel antibody shifts ‘eat me/don’t eat me’ balance in refractory NHL

June 6, 2018

Follicular Lymphoma

Aggressive B-Cell Non-Hodgkin Lymphoma

June 4, 2018

Umbralisib has ‘distinct’ safety profile

May 16, 2018

Follicular Lymphoma

2017 notches up some landmark approvals

May 14, 2018

Follicular Lymphoma

Drug granted fast track designations for FL, DLBCL

May 5, 2018

Follicular Lymphoma

Early results favor combo IL-15/anti-CD20 in indolent NHL

May 3, 2018

Follicular Lymphoma

Novartis CAR T-cell therapy adds a lymphoma indication

May 3, 2018

FDA issues CRL for proposed biosimilar rituximab

May 3, 2018

Follicular Lymphoma

FDA approves CAR T-cell therapy for lymphoma

May 2, 2018

Team identifies 5 subtypes of DLBCL

May 1, 2018

Follicular Lymphoma